<DOC>
	<DOCNO>NCT00922272</DOCNO>
	<brief_summary>To explore efficacy SPD489 , adjunctive therapy stable dose atypical antipsychotic medication , negative symptom adult subject clinically stable schizophrenia predominant negative symptom , measure Scale Assessment Negative Symptoms ( SANS ) .</brief_summary>
	<brief_title>Efficacy , Safety , Tolerability SPD489 Adults With Schizophrenia Predominant Negative Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Adults age 1855 Clinically stable Schizophrenia predominant negative symptom Taking stable dose antipsychotic medication Clinically notable positive symptom define PANSS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>